Honeydew honey as a potent antibacterial agent in eradication of multi-drug resistant Stenotrophomonas maltophilia isolates from cancer patients

Phytotherapy Research

Volumn 25, Issue 4, 2011, Pages 584-587

  Majtan, Juraj ^a,b   Majtanova, Lubica ^b   Bohova, Jana ^a   Majtan, Viktor ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

antibacterial; honey; honeydew; manuka; multi drug resistance; Stenotrophomonas maltophilia

Indexed keywords

ANTIBIOTIC AGENT; MANUKA; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANCER PATIENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; ERADICATION THERAPY; HONEYDEW; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; HONEY; HUMANS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; STENOTROPHOMONAS MALTOPHILIA;

CUCUMIS MELO VAR. INODORUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 79953191130     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3304     Document Type: Article

References (29)

1. Adams CJ, Boult CH, Deadman BJ, et al. 2008. Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343: 651-659.
2. Aljadi AM, Yusoff KM,. 2003. Isolation and identification of phenolic acids in Malaysian honey with antibacterial properties. Turk J Med Sci 33: 229-236. (Pubitemid 37013756)
3. Allen KL, Molan PC, Reid GM,. 1991. A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43: 817-822.
4. Blair SE, Carter DA,. 2005. The potential for honey in the management of wounds and infections. J Aust Infect Control 10: 24-31.
5. Clinical and Laboratory Standards Institute. 2003. Methods for Dilution of Antimicrobial Susceptibility Tests for Bacteria that Growth Aerobically, 6th edn. Approved standard M7-A6. CLSI/NCCLS M7-A6. The Institute: Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement. CLSI/NCCLS M100-S15. The Institute: Wayne, PA.
7. Dowd SE, Sun Y, Secor PR, et al. 2008. Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8: 1-15.
8. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E,. 2008. Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 46: 3774-3779.
9. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J,. 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32: S104-S132.
10. George NM, Cutting KF,. 2007. Antibacterial honey (Medihoney™): in vitro activity against clinical isolates of MRSA, VRE and other multiresistant gram-negative organisms including Pseudomonas aeruginosa. Wounds 19: 231-236.
11. Gomez-Caravaca AM, Gomez-Romero M, Arraez-Roman D, Segura-Carretero A, Fernandez-Gutierrez A., 2006. Advances in the analysis of phenolic compounds in products derived from bees. J Pharm Biomed Anal 41: 1220-1234. (Pubitemid 43775880)
12. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, Giovanoli P,. 2009. Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986-2005). Burns 35: 553-560.
13. Khardori N, Elting L, Wong E, Schable B, Bodey GP,. 1990. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 12: 997-1003.
14. Kwakman PH, te Velde AA, De Boer L, Speijer D, Vandenbroucke-Grauls CM, Zaat SA., 2010. How honey kills bacteria. FASEB J 24: 2576-2582.
15. Lin SM, Molan PC, Cursons RT,. 2009. The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey. Eur J Clin Microbiol Infect Dis 28: 339-344.
16. Looney WJ, Narita M, Muhlemann K,. 2009. Stenotrophomonas maltophilia: an emerging opportunistic human pathogen. Lancet Infect Dis 9: 312-323.
17. Lusby PE, Coombes AL, Wilkinson JM,. 2005. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 36: 464-467. (Pubitemid 41140049)
18. Mavric E, Wittmann S, Barth G, Henle T,. 2008. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52: 483-489.
19. Molan PC., 1992. The antibacterial nature of honey. 1. The nature of the antibacterial activity. Bee World 73: 5-28.
20. Molan PC., 2006. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds 5: 40-54. (Pubitemid 43260786)
21. Nicodemo AC, Paez JI,. 2007. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26: 229-237. (Pubitemid 46572029)
22. Paez JI, Costa SF,. 2008. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 70: 101-108.
23. Safdar A, Rolston KV,. 2007. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45: 1602-1609. (Pubitemid 351411846)
24. San Gabriel P, Zhou J, Tabibi S, Chen Y, Trauzzi M, Saiman L., 2004. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 48: 168-171. (Pubitemid 38040193)
25. Tan HT, Rahman RA, Gan SH, et al. 2009. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement Altern Med 9: 34.
26. Taormina PJ, Niemera BA, Beuchat LR,. 2001. Inhibitory activity of honey against foodborne pathogens as influenced by the presence of hydrogen peroxide and level of antioxidant power. Int J Food Microbiol 69: 217-225. (Pubitemid 32826260)
27. Vartivarian SE, Anaissie EJ, Bodey GP, Sprigg H, Rolston KV,. 1994. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 38: 624-627. (Pubitemid 24072261)
28. Wahdan HA., 1998. Causes of the antimicrobial activity of honey. Infection 26: 26-31. (Pubitemid 28062156)
29. Zhang L, Li XZ, Poole K,. 2000. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother 44: 287-293. (Pubitemid 30060721)